SEC Form 4 · accession 0000899243-16-015484
AGENUS INC · AGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Garo H Armen
Officer — Chairman & CEO
Period of report
Mar 7, 2016
Accepted (ET)
Mar 8, 2016 · 11:35 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001098972
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 7, 2016 | P | 200,000 | $4.028 | A | 1,251,228 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Dr. Armen's purchase of Agenus Inc. common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, with Dr. Armen's sale of an equivalent number of shares of Agenus common stock at a weighted average price of $4.5919 per share on December 28 and December 29, 2015. Dr. Armen has paid to Agenus, as of March 8, 2016, $96,035.81, representing the full amount of the profit realized in connection with the short-swing transaction.